Adapting HIV services for pregnant and breastfeeding women, infants, children, adolescents and families in resource-constrained settings during the COVID-19 pandemic.
Adolescent
Betacoronavirus
Breast Feeding
COVID-19
Child
Child, Preschool
Coronavirus Infections
/ epidemiology
Delivery of Health Care
Family
Female
HIV Infections
/ diagnosis
Health Resources
Humans
Infant
Pandemics
/ prevention & control
Pneumonia, Viral
/ epidemiology
Pregnancy
Pregnancy Complications, Infectious
/ drug therapy
SARS-CoV-2
Viral Load
COVID-19
HIV
adolescents
children
family-centred |
maternal
Journal
Journal of the International AIDS Society
ISSN: 1758-2652
Titre abrégé: J Int AIDS Soc
Pays: Switzerland
ID NLM: 101478566
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
04
05
2020
revised:
06
08
2020
accepted:
04
09
2020
entrez:
30
9
2020
pubmed:
1
10
2020
medline:
6
10
2020
Statut:
ppublish
Résumé
The COVID-19 pandemic has impacted global health service delivery, including provision of HIV services. Countries with high HIV burden are balancing the need to minimize interactions with health facilities to reduce the risk of COVID-19 transmission, while delivering uninterrupted essential HIV prevention, testing and treatment services. Many of these adaptations in resource-constrained settings have not adequately accounted for the needs of pregnant and breastfeeding women, infants, children and adolescents. We propose whole-family, tailored programme adaptations along the HIV clinical continuum to protect the programmatic gains made in services. Essential HIV case-finding services for pregnant and breastfeeding women and children should be maintained and include maternal testing, diagnostic testing for infants exposed to HIV, index testing for children whose biological parents or siblings are living with HIV, as well as for children/adolescents presenting with symptoms concerning for HIV and comorbidities. HIV self-testing for children two years of age and older should be supported with caregiver and provider education. Adaptations include bundling services in the same visit and providing testing outside of facilities to the extent possible to reduce exposure risk to COVID-19. Virtual platforms can be used to identify vulnerable children at risk of HIV infection, abuse, harm or violence, and link them to necessary clinical and psychosocial support services. HIV treatment service adaptations for families should focus on family based differentiated service delivery models, including community-based ART initiation and multi-month ART dispensing. Viral load monitoring should not be a barrier to transitioning children and adolescents experiencing treatment failure to more effective ART regimens, and viral load monitoring for pregnant and breastfeeding women and children should be prioritized and bundled with other essential services. Protecting pregnant and breastfeeding women, infants, children and adolescents from acquiring SARS-CoV-2 while sustaining essential HIV services is an immense global health challenge. Tailored, family friendly programme adaptations for case-finding, ART delivery and viral load monitoring for these populations have the potential to limit SARS-CoV-2 transmission while ensuring the continuity of life-saving HIV case identification and treatment efforts.
Identifiants
pubmed: 32996705
doi: 10.1002/jia2.25622
pmc: PMC7525801
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e25622Subventions
Organisme : U.S. President's Emergency Plan for AIDS Relief
Pays : International
Informations de copyright
2020. This article is a U.S. Government work and is in the public domain in the USA. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of International AIDS Society.
Références
J Int AIDS Soc. 2018 Feb;21 Suppl 1:
pubmed: 29485714
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
Lancet HIV. 2018 Jan;5(1):e12-e22
pubmed: 29150377
N Engl J Med. 2020 Jul 16;383(3):e11
pubmed: 32302075
Lancet HIV. 2020 May;7(5):e314-e316
pubmed: 32304642
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 May 10;41(5):662-666
pubmed: 32223840
J Int AIDS Soc. 2020 Apr;23(4):e25482
pubmed: 32239657
AIDS Behav. 2020 Aug;24(8):2229-2231
pubmed: 32285221
N Engl J Med. 2015 Aug 27;373(9):808-22
pubmed: 26193126
AIDS Care. 2020 Apr 16;:1-5
pubmed: 32295406
J Int AIDS Soc. 2020 May;23(5):e25503
pubmed: 32378345
Lancet. 2020 Feb 15;395(10223):514-523
pubmed: 31986261
J Int AIDS Soc. 2019 Apr;22(4):e25272
pubmed: 30983148
Clin Infect Dis. 2020 Aug 29;:
pubmed: 32860699
Infection. 2020 Oct;48(5):681-686
pubmed: 32394344
Lancet HIV. 2019 Oct;6(10):e646-e648
pubmed: 31416796
Curr HIV/AIDS Rep. 2016 Dec;13(6):359-366
pubmed: 27739018
Lancet. 2009 Dec 19;374(9707):2080-2089
pubmed: 19939445
Lancet HIV. 2020 May;7(5):e308-e309
pubmed: 32272084